Stock listing
NEWCONNECT:GX1 genXone SA Akcje
Follow genXone SA into a list and get an email when it puts out news.
Share price · NEWCONNECT:GX1
4.26 PLN -0.02 (-0.5%)
Close on Nov 20, 2026
- Day range
- 4.26 – 4.26 PLNNov 20, 2026
- Volume
- 5 sharesNov 20, 2026
- Market cap
- 14.08M PLNAt the close on Nov 20, 2026 · price × 3.30M shares outstanding
- 52-week range
- 3.81 – 6.96 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 3,480 PLNMedian day 155 shares · 3 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NEWCONNECT:GX1 · PLN, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 4.26 | -0.02 | -0.5% | 4.26 | 4.26 | 4.26 | 5 | |
| 4.28 | -0.30 | -6.6% | 4.44 | 4.44 | 3.84 | 3,713 | |
| 4.58 | 0.00 | 0.0% | 4.58 | 4.58 | 4.58 | 0 | |
| 4.58 | -0.02 | -0.4% | 4.58 | 4.58 | 4.58 | 3 | |
| 4.60 | 0.00 | 0.0% | 4.60 | 4.60 | 4.60 | 3 | |
| 4.60 | +0.03 | +0.7% | 4.57 | 4.76 | 4.57 | 1,041 | |
| 4.57 | -0.19 | -4.0% | 4.57 | 4.57 | 4.57 | 20 | |
| 4.76 | +0.26 | +5.8% | 4.68 | 4.76 | 4.68 | 80 | |
| 4.50 | -0.30 | -6.2% | 4.70 | 4.80 | 4.50 | 2,275 | |
| 4.80 | -0.16 | -3.2% | 4.88 | 4.96 | 4.71 | 416 | |
| 4.96 | +0.06 | +1.2% | 4.82 | 4.96 | 4.74 | 145 | |
| 4.90 | -0.48 | -8.9% | 5.26 | 5.26 | 4.88 | 3,075 | |
| 5.38 | +0.12 | +2.3% | 5.38 | 5.38 | 5.38 | 2 | |
| 5.26 | -0.04 | -0.8% | 5.28 | 5.28 | 5.26 | 60 | |
| 5.30 | -0.10 | -1.9% | 5.38 | 5.38 | 5.30 | 165 | |
| 5.40 | 0.00 | 0.0% | 5.40 | 5.40 | 5.40 | 0 | |
| 5.40 | 0.00 | 0.0% | 5.40 | 5.40 | 5.40 | 0 | |
| 5.40 | -0.10 | -1.8% | 5.48 | 5.62 | 5.40 | 417 | |
| 5.50 | -0.10 | -1.8% | 5.60 | 5.60 | 5.50 | 122 | |
| 5.60 | +0.06 | +1.1% | 5.66 | 5.76 | 5.46 | 576 | |
| 5.54 | -0.16 | -2.8% | 5.56 | 5.76 | 5.54 | 286 | |
| 5.70 | +0.10 | +1.8% | 5.64 | 5.70 | 5.44 | 351 | |
| 5.60 | -0.16 | -2.8% | 5.64 | 5.64 | 5.60 | 48 | |
| 5.76 | -0.02 | -0.3% | 5.78 | 5.78 | 5.76 | 22 | |
| 5.78 | +0.02 | +0.3% | 5.76 | 5.78 | 5.76 | 4 | |
| 5.76 | +0.46 | +8.7% | 5.18 | 5.82 | 5.04 | 3,319 | |
| 5.30 | -0.56 | -9.6% | 5.86 | 5.86 | 5.18 | 1,320 | |
| 5.86 | -0.04 | -0.7% | 5.86 | 5.86 | 5.86 | 20 | |
| 5.90 | +0.10 | +1.7% | 5.80 | 5.90 | 5.80 | 242 | |
| 5.80 | -0.12 | -2.0% | 5.92 | 5.92 | 5.74 | 144 | |
| 5.92 | -0.02 | -0.3% | 5.92 | 6.00 | 5.80 | 787 | |
| 5.94 | -0.06 | -1.0% | 5.96 | 5.96 | 5.78 | 73 | |
| 6.00 | +0.10 | +1.7% | 5.88 | 6.20 | 5.78 | 496 | |
| 5.90 | 0.00 | 0.0% | 5.90 | 5.90 | 5.90 | 2 | |
| 5.90 | -0.12 | -2.0% | 5.92 | 5.92 | 5.82 | 27 | |
| 6.02 | +0.78 | +14.9% | 5.22 | 6.08 | 5.22 | 3,365 | |
| 5.24 | 0.00 | 0.0% | 5.24 | 5.24 | 5.24 | 2 | |
| 5.24 | 0.00 | 0.0% | 5.14 | 5.24 | 5.14 | 45 | |
| 5.24 | +0.08 | +1.6% | 5.00 | 5.24 | 5.00 | 499 | |
| 5.16 | -0.02 | -0.4% | 5.18 | 5.18 | 4.62 | 1,760 | |
| 5.18 | 0.00 | 0.0% | 5.18 | 5.18 | 5.18 | 2 | |
| 5.18 | -0.12 | -2.3% | 5.30 | 5.30 | 5.06 | 593 | |
| 5.30 | -0.06 | -1.1% | 5.38 | 5.38 | 5.18 | 294 | |
| 5.36 | +0.06 | +1.1% | 5.36 | 5.36 | 5.36 | 2 | |
| 5.30 | +0.02 | +0.4% | 5.38 | 5.38 | 5.30 | 28 | |
| 5.28 | -0.10 | -1.9% | 5.38 | 5.38 | 5.28 | 108 | |
| 5.38 | -0.22 | -3.9% | 5.36 | 5.78 | 5.18 | 571 | |
| 5.60 | -0.30 | -5.1% | 5.56 | 5.88 | 5.04 | 2,211 | |
| 5.90 | 0.00 | 0.0% | 5.90 | 5.90 | 5.22 | 1,476 | |
| 5.90 | 0.00 | 0.0% | 5.90 | 5.90 | 5.90 | 32 | |
| 5.90 | -0.04 | -0.7% | 5.90 | 5.92 | 5.90 | 22 | |
| 5.94 | +0.02 | +0.3% | 5.76 | 5.94 | 5.60 | 714 | |
| 5.92 | +0.14 | +2.4% | 5.78 | 5.92 | 5.58 | 1,749 | |
| 5.78 | +0.34 | +6.2% | 5.44 | 5.80 | 5.44 | 1,304 | |
| 5.44 | -0.02 | -0.4% | 5.46 | 5.46 | 5.44 | 321 | |
| 5.46 | +0.02 | +0.4% | 5.46 | 5.46 | 5.30 | 511 | |
| 5.44 | 0.00 | 0.0% | 5.46 | 5.46 | 5.30 | 134 | |
| 5.44 | -0.18 | -3.2% | 5.52 | 5.58 | 5.30 | 604 | |
| 5.62 | 0.00 | 0.0% | 5.62 | 5.62 | 5.20 | 4,814 | |
| 5.62 | +0.12 | +2.2% | 5.50 | 5.72 | 5.40 | 521 | |
| 5.50 | -0.24 | -4.2% | 5.72 | 5.74 | 5.50 | 393 | |
| 5.74 | -0.04 | -0.7% | 5.74 | 5.74 | 5.74 | 2 | |
| 5.78 | +0.08 | +1.4% | 5.70 | 5.78 | 5.70 | 68 | |
| 5.70 | +0.10 | +1.8% | 5.70 | 5.70 | 5.70 | 24 |
- Ticker
- NEWCONNECT:GX1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NEWCONNECT
- Currency
- PLN
What changed lately
Latest news release · Jun 19, 2026
Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Latest news
Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Jun 19, 2026
Closed 5.90 (+7.3%) on Jun 19, 2026
Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
May 28, 2026
Closed 5.92 (+1.4%) on May 28, 2026
Genxone FY Net Loss 2.6 Million Zlotys
Apr 23, 2026
Closed 6.34 (0.0%) on Apr 23, 2026
Genxone Offer For DNA Sequencing Project Chosen As Most Favourable By Medical University Of Warsaw
Apr 14, 2026
Closed 6.50 (+2.5%) on Apr 14, 2026
Genxone Signs Deal With National Institute Of Geriatrics For Microbiome Sequencing Services
Mar 18, 2026
Closed 5.98 (0.0%) on Mar 18, 2026
Genxone Offer For Microbiome Sequencing Services Chosen As Most Favorable In Tender
Feb 17, 2026
Closed 5.80 (+12.4%) on Feb 18, 2026
genXone Q4 Net Loss At 0.2 Million Zlotys
Feb 11, 2026
Closed 5.06 (+8.8%) on Feb 12, 2026
genXone SA on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 7 in the last 12 months · 9 in all · newest Jun 19, 2026 · oldest 2025
- Decks
- 3 decks · latest March 2021
Valuation
EV/sales 4.5× against a median of 8.5×: 4th lowest of 9 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 11.22M PLN
- P/E
- Loss
- EV/sales
- 4.5×
- EV/EBITDA
- 18.6×
- Price/book
- 1.9×
- Gross margin
- 56.2%
- Operating margin
- −74.5%
- Net margin
- −67.9%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| genXone SA · NEWCONNECT:GX1 | US$3.47M | US$2.76M | n/a | 4.5× | 18.6× | 1.9× | −67.9% | 0.0× | n/a |
| BioInfra Co.,Ltd. · KRX:199730 | US$4.75M | −US$509,202 | n/a | −0.0× | n/a | 0.5× | −32.3% | 0.0× | n/a |
| Cardio Diagnostics Holdings Inc. · NASDAQ:CDIO | US$4.74M | US$4.74M | n/a | 312× | n/a | 0.8× | n/a | 0.0× | 2.07 |
| Niki BioSolutions, Inc. · NASDAQ:NIKI | US$4.61M | US$4.60M | n/a | n/a | n/a | 0.2× | n/a | 0.1× | 1.46 |
| Cambridge Nutritional Sciences PLC · LSE:CNSL | US$4.51M | US$1.23M | n/a | 0.1× | n/a | 0.6× | −83.5% | 0.0× | n/a |
| Proteome Sciences plc · LSE:PRM | US$4.45M | US$23.87M | n/a | 4.9× | n/a | n/a | −81.5% | n/a | n/a |
| Immunovia AB · OMXSTO:IMMNOV | US$3.95M | US$2.31M | n/a | 12.1× | n/a | 6.1× | n/a | 0.4× | n/a |
| SDS Optic Spolka Akcyjna · NEWCONNECT:SDS | US$3.81M | US$3.57M | n/a | 13.7× | n/a | 11.8× | −269.4% | 0.0× | n/a |
| Telo Genomics Corp. · TSXV:TELO | US$2.80M | US$2.12M | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 |
| Advanced Biomed Inc. · NASDAQ:ADVB | US$2.73M | US$3.12M | 0.5× | 12.2× | n/a | 0.2× | n/a | 0.1× | 0.35 |
| Innovotech Inc. · TSXV:IOT | US$2.66M | US$2.51M | n/a | 1.0× | n/a | 1.5× | −21.1% | 0.1× | 0.39 |
| Median of the others | US$4.20M | US$2.81M | 0.5× | 8.5× | 0.7× | −81.5% | 0.0× | 0.39 |
Team and board
| Officer | Role |
|---|---|
| Prezes genXone | CEO |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2021) | Investor deck | 10 slides | March 2021 |
| Investor Presentation (August 2020) | Investor deck | 9 slides | Aug 25, 2020 |
| Investor Presentation (August 2020) | Investor deck | 14 slides | August 2020 |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 2.34M | 1.79M | 2.39M | 10.6M |
| Cost of revenue | 989.7K | 1.15M | 1.80M | 4.63M |
| Gross profit | 1.35M | 640.3K | 597.1K | 5.96M |
| Selling, general and administrative | 1.82M | |||
| Operating income | -2.38M | -3.69M | -4.24M | 238.1K |
| Depreciation and amortization | 1.09M | 1.35M | 1.35M | 1.54M |
| EBITDA | -1.29M | -2.33M | -2.89M | 1.78M |
| Interest expense | 60 | 3.48K | 7.53K | 5.39K |
| Income before tax | -2.64M | -3.93M | -3.72M | 630.1K |
| Net income | -2.64M | -3.93M | -3.72M | 480.0K |
| Earnings per share, basic | -0.80 | -1.19 | -1.13 | 0.15 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 3.36M | 5.45M | 7.00M | 11.2M |
| Receivables | 475.1K | 176.0K | 769.7K | 214.8K |
| Inventory | 169.1K | 126.9K | 183.7K | 257.1K |
| Current assets | 4.12M | 7.19M | 9.01M | 12.6M |
| Total assets | 8.96M | 11.7M | 15.5M | 19.8M |
| Accounts payable | 73.6K | 135.8K | 92.1K | 250.0K |
| Current liabilities | 552.7K | 643.1K | 532.1K | 1.03M |
| Total liabilities | 552.7K | 643.1K | 532.1K | 1.09M |
| Shareholders' equity | 8.41M | 11.0M | 15.0M | 18.7M |
| Shares outstanding | 3.30M | 3.30M | 3.30M | 3.29M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -2.39M | -2.24M | -4.62M | 335.2K |
| Capital spending | -80.4K | -45.1K | -67.7K | -523.2K |
| Free cash flow | -2.47M | -2.28M | -4.68M | -187.9K |
| Dividends paid | -3.29M | |||
| Share buybacks | 0 | 0 | ||
| Change in cash | -2.09M | -1.55M | -4.17M | -3.07M |
Cap table
Built by 6ix from genXone SA’s releases
- Common shares
- 3,304,800
- Fully diluted
- 3,304,800
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 3,304,800 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 3,304,800 |
Log in to ask 6ix AI your own questions about genXone SA.